Skip to main content
. Author manuscript; available in PMC: 2013 Mar 18.
Published in final edited form as: Antivir Ther. 2011 Nov 18;17(2):313–320. doi: 10.3851/IMP1985

Figure 2. HIV-1 antiretroviral resistance patterns in 70 participants experiencing viral rebound on first-line therapy in the CIPRA-SAb study in South Africa.

Figure 2

a Participants on a PIs-based regimen are represented by black asterisks, if they were also exposed to sdNVP to prevent mother-to-child-transmission the asterisks is red.

b CIPRA-SA is the Comprehensive International Program of Research on AIDS-South Africa.